Acorah Software Products - Accounts Production 15.0.600 false true 31 January 2023 31 October 2021 false 30 October 2024 true 1 February 2023 31 January 2024 31 January 2024 10085603 Mr Martin Stratton Mr Paul Doherty iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10085603 2023-01-31 10085603 2024-01-31 10085603 2023-02-01 2024-01-31 10085603 frs-core:CurrentFinancialInstruments 2024-01-31 10085603 frs-core:FurnitureFittings 2024-01-31 10085603 frs-core:FurnitureFittings 2023-02-01 2024-01-31 10085603 frs-core:FurnitureFittings 2023-01-31 10085603 frs-core:NetGoodwill 2024-01-31 10085603 frs-core:NetGoodwill 2023-02-01 2024-01-31 10085603 frs-core:NetGoodwill 2023-01-31 10085603 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-01-31 10085603 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2023-02-01 2024-01-31 10085603 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2023-01-31 10085603 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-01-31 10085603 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-02-01 2024-01-31 10085603 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-01-31 10085603 frs-core:MotorVehicles 2024-01-31 10085603 frs-core:MotorVehicles 2023-02-01 2024-01-31 10085603 frs-core:MotorVehicles 2023-01-31 10085603 frs-core:ShareCapital 2024-01-31 10085603 frs-core:RetainedEarningsAccumulatedLosses 2023-02-01 2024-01-31 10085603 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31 10085603 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 10085603 frs-bus:FullAccounts 2023-02-01 2024-01-31 10085603 frs-bus:MediumEntities 2023-02-01 2024-01-31 10085603 frs-bus:Audited 2023-02-01 2024-01-31 10085603 frs-bus:Medium-sizedCompaniesRegimeForAccounts 2023-02-01 2024-01-31 10085603 frs-bus:Medium-sizedCompaniesRegimeForDirectorsReport 2023-02-01 2024-01-31 10085603 frs-bus:OrdinaryShareClass1 2023-02-01 2024-01-31 10085603 frs-bus:OrdinaryShareClass1 2024-01-31 10085603 frs-core:DeferredTaxation 2023-02-01 2024-01-31 10085603 frs-core:DeferredTaxation 2023-01-31 10085603 frs-core:DeferredTaxation 2024-01-31 10085603 frs-core:UnlistedNon-exchangeTraded 2024-01-31 10085603 frs-core:UnlistedNon-exchangeTraded 2023-01-31 10085603 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-01-31 10085603 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-01-31 10085603 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-01-31 10085603 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-01-31 10085603 frs-bus:Director1 2023-02-01 2024-01-31 10085603 frs-bus:Director2 2023-02-01 2024-01-31 10085603 1 2023-02-01 2024-01-31 10085603 1 2023-02-01 2024-01-31 10085603 frs-countries:EnglandWales 2023-02-01 2024-01-31 10085603 2021-10-30 10085603 2023-01-31 10085603 2021-10-31 2023-01-31 10085603 frs-core:CurrentFinancialInstruments 2023-01-31 10085603 frs-core:ShareCapital 2021-10-30 10085603 frs-core:ShareCapital 2023-01-31 10085603 frs-core:RetainedEarningsAccumulatedLosses 2021-10-31 2023-01-31 10085603 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2021-10-30 10085603 frs-core:RetainedEarningsAccumulatedLosses 2023-01-31 10085603 frs-bus:OrdinaryShareClass1 2021-10-31 2023-01-31 10085603 1 2021-10-31 2023-01-31
Registered number: 10085603
AIM RX Ltd
Strategic Report, Directors' Report and
Financial Statements
For The Year Ended 31 January 2024
Contents
Page
Strategic Report 1—2
Directors' Report 3—4
Independent Auditor's Report 5—8
Profit and Loss Account 9
Statement of Comprehensive Income 10
Balance Sheet 11—12
Statement of Changes in Equity 13
Statement of Cash Flows 14
Notes to the Statement of Cash Flows 15
Notes to the Financial Statements 16—22
Page 1
Strategic Report
The directors present their strategic report for the year ended 31 January 2024.
Review of the Business
The financial year has shown a trading Operating Profit for the year of £213,592 (2023; £307,750) which is lower than the previous year. In actual terms the profit has been very similar when you take into account that 2024 is a 12 month period and 2023 was a 15 month period.
Once dividend income from Click Trading Ltd and profit from disposal of the pharmacy at Stanney Lane is taken into account the profit before taxation is £660,944 (2023; £303,079). 
Investments include Click Trading Limited in which Aim RX Limited has a 50% shareholding.
Aim RX Limited operates 9 pharmacies (2023; 10 pharmacies). 
Principal Risks and Uncertainties
Critical to the company’s achievement of its objectives is effective risk management. The company faces risk from a number of areas, all of which are prevalent throughout the industry and are shown below.
Sales and purchases are made in sterling hence the business has very little exposure to foreign exchange risk. 
Government regulation affects the pharmaceutical business which we monitor to make changes when necessary.
The business manages the liquidity risk by ensuring there are sufficient funds to meet payments with strict cashflow and credit control management and by having a good long term relationship with its bank.
Future Developments
Aim RX Ltd continually reviews performance of the business and future development.  Regular reviews are undertaken by management to increase turnover and reduce costs.
Dividends
The dividends paid to the parent company BBE Developments Ltd amounted to £418,210 (2023; £2,299,438).
Post Balance Sheet Events
There are no financial events that have occurred after the date on the balance sheet which could affect the company’s finances for the foreseeable future.
Page 1
Page 2
Key Performance indicators
Financial key performance indicators
The main key performance indicators were as follows:
Gross profit margin: 2024 – 30.79% (2023 – 32.47%).
Gross profit: 2024 - £4,840,655 (2023 - £5,789,322).
Net profit Pre-Tax margin: 2024 – 3.35% (2023 – 1.70%).
Net profit Pre-Tax: 2024 - £525,944 (2023 - £303,079).
The key performance indicators are monitored by the board to ensure that they are progressing as planned in a timely manner. At this stage the directors are confident that these targets are being met.
On behalf of the board
Mr Martin Stratton
Director
30/10/2024
Page 2
Page 3
Directors' Report
The directors present their report and the financial statements for the year ended 31 January 2024.
Principal Activity
The company's principal activity continues to be that of a pharmacy.
Directors
The directors who held office during the year were as follows:
Mr Martin Stratton
Mr Paul Doherty
Matters covered in the Strategic Report
Disclosures required under s416(4) of the Companies Act 2006 are commented upon in the Strategic Report as the directors consider them to be of strategic importance to the business.
Statement of Directors' Responsibilities
The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising FRS102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the directors are required to:
  • select suitable accounting policies and then apply them consistently;
  • make judgments and accounting estimates that are reasonable and prudent;
  • state whether applicable United Kingdom Accounting Standards, comprising FRS102, have been followed subject to any material departures disclosed and explained in the financial statements;
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Statement of Disclosure of Information to Auditors
In the case of each director in office at the date the Directors' Report is approved:
  • so far as the director is aware, there is no relevant audit information of which the company's auditors are unaware; and
  • they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information.
Page 3
Page 4
Independent Auditors
The auditors, Ilyas Patel (Accountants) Limited, have indicated their willingness to continue in office and a resolution concerning their re-appointment will be proposed at the Annual General Meeting.
On behalf of the board
Mr Martin Stratton
Director
30/10/2024
Page 4
Page 5
Independent Auditor's Report
Opinion
We have audited the financial statements of AIM RX Ltd for the year ended 31 January 2024 which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes of Equity, Cash Flow Statement and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
In our opinion the financial statements:
  • give a true and fair view of the state of the company's affairs as at 31 January 2024 and of its profit/(loss) for the year then ended;
  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
  • have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions Relating to Going Concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Page 5
Page 6
Opinions on Other Matters Prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
  • the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
  • the directors' report has been prepared in accordance with applicable legal requirements.
Matters on Which We Are Required to Report by Exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us;
  • the financial statements are not in agreement with the accounting records or returns;
  • certain disclosures of directors' remuneration specified by law are not made;
  • we have not received all the information and explanations we require for our audit, or
  • the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemptions in preparing the directors' report and from the requirement to prepare a strategic report.
Responsibilities of Directors
As explained more fully in the Directors' Responsibilities Statement set out on page 3—4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Page 6
Page 7
Auditor's Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
• the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non compliance with applicable laws and regulations.
• we identified the laws and regulations applicable to the company through discussions with directors and other management;
• we assessed the extent of compliance with laws and regulations identified above through making enquiries of management and inspecting legal correspondence;
• the identified laws and regulations were communicated within the audit team regularly and the team remained alert to any instances on non-compliance throughout the audit.
We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by;
• making enquiries management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
• considering the internal controls in place to mitigate risks of fraud and none-compliance with laws and regulations.
To address the risk of fraud through management bias and overide of controls, we;
• performed analytical procedures to identify an unusual or unexpected relationships;
• tested journal entries to identify unusual transactions;
• assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and
• investigated and evaluated the business rationale of significant transactions outside the normal course of business.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but not limited to:
• reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.
• evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation (ie. gives a true and fair view).
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This increases the more the compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities accruing due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.
Page 7
Page 8
Use Of Our Report
This report is made solely to the company's members, as a body, in accordance with the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters that we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Ilyas Patel (Senior Statutory Auditor)
for and on behalf of Ilyas Patel (Accountants) Limited , Statutory Auditor
30/10/2024
Page 8
Page 9
Profit and Loss Account
31 January 2024 31 January 2023
Notes £ £
TURNOVER 15,722,328 17,831,153
Cost of sales (10,881,673 ) (12,041,831 )
GROSS PROFIT 4,840,655 5,789,322
Administrative expenses (4,775,798 ) (5,498,538 )
Other operating income 13,735 16,966
OPERATING PROFIT 3 78,592 307,750
Income from other fixed asset investments 50,000 -
Profit/(loss) on disposal of fixed assets 397,587 (1,166 )
Interest payable and similar charges 9 (235 ) (3,505 )
PROFIT BEFORE TAXATION 525,944 303,079
Tax on Profit 10 (38,879 ) (32,800 )
PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR 487,065 270,279
The notes on pages 15 to 22 form part of these financial statements.
Page 9
Page 10
Statement of Comprehensive Income
31 January 2024 31 January 2023
£ £
PROFIT FOR THE FINANCIAL YEAR 487,065 270,279
OTHER COMPREHENSIVE INCOME FOR THE YEAR - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 487,065 270,279
Page 10
Page 11
Balance Sheet
Registered number: 10085603
31 January 2024 31 January 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 11 220,875 249,375
Tangible Assets 12 424,613 440,746
Investments 13 423,134 423,134
1,068,622 1,113,255
CURRENT ASSETS
Stocks 14 451,508 433,029
Debtors 15 1,599,738 1,626,157
Cash at bank and in hand 1,645,171 1,319,311
3,696,417 3,378,497
Creditors: Amounts Falling Due Within One Year 16 (2,544,732 ) (2,350,232 )
NET CURRENT ASSETS (LIABILITIES) 1,151,685 1,028,265
TOTAL ASSETS LESS CURRENT LIABILITIES 2,220,307 2,141,520
PROVISIONS FOR LIABILITIES
Deferred Taxation 17 (24,765 ) (14,833 )
NET ASSETS 2,195,542 2,126,687
CAPITAL AND RESERVES
Called up share capital 19 1 1
Profit and Loss Account 2,195,541 2,126,686
SHAREHOLDERS' FUNDS 2,195,542 2,126,687
Page 11
Page 12
On behalf of the board
Mr Martin Stratton
Director
30/10/2024
The notes on pages 15 to 22 form part of these financial statements.
Page 12
Page 13
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 31 October 2021 1 4,155,845 4,155,846
Profit for the period and total comprehensive income - 270,279 270,279
Dividends paid - (2,299,438) (2,299,438)
As at 31 January 2023 and 1 February 2023 1 2,126,686 2,126,687
Profit for the year and total comprehensive income - 487,065 487,065
Dividends paid - (418,210) (418,210)
As at 31 January 2024 1 2,195,541 2,195,542
Page 13
Page 14
Statement of Cash Flows
31 January 2024 31 January 2023
Notes £ £
Cash flows from operating activities
Net cash generated from operations 1 433,598 3,207,277
Interest paid (235 ) (3,505 )
Tax paid (68,380 ) (272,348 )
Net cash generated from operating activities 364,983 2,931,424
Cash flows from investing activities
Purchase of intangible assets - (285,000 )
Purchase of tangible assets (68,500 ) (83,504 )
Proceeds from disposal of tangible assets 397,587 284,999
Purchase of other fixed asset investments - (705,134 )
Proceeds from disposal of other fixed asset investments - 282,000
Dividends received 50,000 -
Net cash generated from/(used in) investing activities 379,087 (506,639 )
Cash flows from financing activities
Equity dividends paid (418,210 ) (2,299,438 )
Increase in cash and cash equivalents 325,860 125,347
Cash and cash equivalents at beginning of year 2 1,319,311 1,193,964
Cash and cash equivalents at end of year 2 1,645,171 1,319,311
Page 14
Page 15
Notes to the Statement of Cash Flows
1. Reconciliation of profit for the financial year to cash generated from operations
31 January 2024 31 January 2023
£ £
Profit for the financial year 487,065 270,279
Adjustments for:
Tax on profit 38,879 32,800
Interest expense 235 3,505
Income from investments (50,000) -
Amortisation of intangible assets 28,500 35,625
Depreciation of tangible assets 84,633 101,550
(Profit)/loss on disposal of tangible assets (397,587) 1,166
Movements in working capital:
Increase in stocks (18,479 ) (60,483 )
Decrease in trade and other debtors 26,419 2,401,086
Increase in trade and other creditors 233,933 421,749
Net cash generated from operations 433,598 3,207,277
2. Cash and cash equivalents
Cash and cash equivalents, as stated in the Statement of Cash Flows, relates to the following items in the Balance Sheet:
31 January 2024 31 January 2023
£ £
Cash at bank and in hand 1,645,171 1,319,311
3. Analysis of changes in net funds
As at 1 February 2023 Cash flows As at 31 January 2024
£ £ £
Cash at bank and in hand 1,319,311 325,860 1,645,171
Page 15
Page 16
Notes to the Financial Statements
1. General Information
AIM RX Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10085603 . The registered office is Appleton Village Pharmacy, Appleton Village, Widnes, Cheshire, WA8 6EQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold None
Leasehold 10% Straight Line
Motor Vehicles 25% Reducing Balance
Fixtures & Fittings 25% Reducing Balance
Page 16
Page 17
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.
Cost is determined using the first-in, first-out method. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Work in progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
At the end of each reporting period stocks are assessed for impairment. If an item of stock is impaired, the identified stock is reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the profit and loss account. Where a reversal of the impairment is required the impairment charge is reversed, up to the original impairment loss, and is recognised as a credit in the profit and loss account.
2.6. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.7. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 17
Page 18
3. Operating Profit
The operating profit is stated after charging:
31 January 2024 31 January 2023
£ £
Bad debts 438 3,725
Depreciation of tangible fixed assets 84,633 101,550
Amortisation of intangible fixed assets 28,500 35,625
4. Auditor's Remuneration
Remuneration received by the company's auditors and their associates during the year was as follows:
31 January 2024 31 January 2023
£ £
Audit Services
Audit of the company's financial statements 7,500 7,500
5. Staff Costs
Staff costs, including directors' remuneration, were as follows:
31 January 2024 31 January 2023
£ £
Wages and salaries 2,448,997 3,019,345
Social security costs 170,774 203,472
Other pension costs 34,908 42,794
2,654,679 3,265,611
6. Average Number of Employees
Average number of employees, including directors, during the year was as follows:
31 January 2024 31 January 2023
Office and administration 5 5
Sales, marketing and distribution 140 113
145 118
Page 18
Page 19
7. Directors' remuneration
31 January 2024 31 January 2023
£ £
Emoluments 114,500 143,125
8. Interest Receivable and Similar Income
31 January 2024 31 January 2023
£ £
Dividends from other fixed asset investments - unlisted 50,000 -
9. Interest Payable and Similar Charges
31 January 2024 31 January 2023
£ £
Other finance charges 235 3,505
10. Tax on Profit
The tax charge on the profit for the year was as follows:
Tax Rate 31 January 2024 31 January 2023
31 January 2024 31 January 2023 £ £
Current tax
UK Corporation Tax 23.5% 19.0% 28,947 68,577
Deferred Tax
Deferred taxation 9,932 (35,777 )
Total tax charge for the period 38,879 32,800
The actual charge for the year can be reconciled to the expected charge for the year based on the profit and the standard rate of corporation tax as follows:
31 January 2024 31 January 2023
£ £
Profit before tax 525,944 303,079
Tax on profit at 23.5% (UK standard rate) 114,227 57,585
Goodwill/depreciation not allowed for tax (68,269 ) 26,063
...CONTINUED
Page 19
Page 20
Expenses not deductible for tax purposes 30 248
Capital allowances (16,398 ) (15,319 )
Short term timing differences 9,932 (35,777 )
Difference in tax rates (643 ) -
Total tax charge for the period 38,879 32,800
Profit before Tax includes £50,000 Dividends from Subsidiary which has been deducted to reconcile the tax on profit.
11. Intangible Assets
Goodwill
£
Cost
As at 1 February 2023 285,000
As at 31 January 2024 285,000
Amortisation
As at 1 February 2023 35,625
Provided during the period 28,500
As at 31 January 2024 64,125
Net Book Value
As at 31 January 2024 220,875
As at 1 February 2023 249,375
12. Tangible Assets
Land & Property
Freehold Leasehold Motor Vehicles Fixtures & Fittings Total
£ £ £ £ £
Cost
As at 1 February 2023 143,959 373,022 166,519 62,052 745,552
Additions - - 17,350 51,150 68,500
As at 31 January 2024 143,959 373,022 183,869 113,202 814,052
Depreciation
As at 1 February 2023 - 197,060 71,277 36,469 304,806
Provided during the period - 37,302 28,148 19,183 84,633
As at 31 January 2024 - 234,362 99,425 55,652 389,439
Net Book Value
As at 31 January 2024 143,959 138,660 84,444 57,550 424,613
As at 1 February 2023 143,959 175,962 95,242 25,583 440,746
Page 20
Page 21
13. Investments
Unlisted
£
Cost
As at 1 February 2023 423,134
As at 31 January 2024 423,134
Provision
As at 1 February 2023 -
As at 31 January 2024 -
Net Book Value
As at 31 January 2024 423,134
As at 1 February 2023 423,134
14. Stocks
31 January 2024 31 January 2023
£ £
Finished goods 451,508 433,029
15. Debtors
31 January 2024 31 January 2023
£ £
Due within one year
Trade debtors 1,278,865 1,304,169
Other debtors 320,873 321,988
1,599,738 1,626,157
16. Creditors: Amounts Falling Due Within One Year
31 January 2024 31 January 2023
£ £
Trade creditors 2,263,870 2,114,603
Other creditors 48,993 59,596
Corporation tax 82,126 121,559
Taxation and social security 38,743 38,474
Accruals and deferred income 111,000 16,000
2,544,732 2,350,232
Page 21
Page 22
17. Deferred Taxation
The provision for deferred tax is made up as follows:
31 January 2024 31 January 2023
£ £
Other timing differences 24,765 14,833
18. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 February 2023 14,833 14,833
Additions 9,932 9,932
Balance at 31 January 2024 24,765 24,765
19. Share Capital
31 January 2024 31 January 2023
Allotted, called up and fully paid £ £
1 Ordinary Shares of £ 1 each 1 1
20. Pension Commitments
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.
During the year the charge to profit or loss in respect of defined contribution schemes was £34,908 (2023: £42,794).
At the balance sheet date contributions of £NIL were due to the fund and are included in creditors.
21. Dividends
31 January 2024 31 January 2023
£ £
On equity shares:
Final dividend paid 418,210 2,299,438
Page 22